- Home
- HONE vs CRMD Comparison
HONE vs CRMD Comparison
Compare HONE & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HONE
- CRMD
- Stock Information
- Founded
- HONE 1917
- CRMD 2006
- Country
- HONE United States
- CRMD United States
- Employees
- HONE N/A
- CRMD N/A
- Industry
- HONE Major Banks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- HONE Finance
- CRMD Health Care
- Exchange
- HONE Nasdaq
- CRMD Nasdaq
- Market Cap
- HONE 405.4M
- CRMD 464.7M
- IPO Year
- HONE 2016
- CRMD 2010
- Fundamental
- Price
- HONE $11.50
- CRMD $11.66
- Analyst Decision
- HONE Buy
- CRMD Strong Buy
- Analyst Count
- HONE 3
- CRMD 6
- Target Price
- HONE $14.50
- CRMD $15.00
- AVG Volume (30 Days)
- HONE 486.7K
- CRMD 2.2M
- Earning Date
- HONE 04-24-2025
- CRMD 05-06-2025
- Dividend Yield
- HONE 3.14%
- CRMD N/A
- EPS Growth
- HONE 67.30
- CRMD N/A
- EPS
- HONE 0.63
- CRMD 0.28
- Revenue
- HONE $162,776,000.00
- CRMD $82,553,827.00
- Revenue This Year
- HONE N/A
- CRMD $207.65
- Revenue Next Year
- HONE $9.42
- CRMD $50.13
- P/E Ratio
- HONE $18.38
- CRMD $42.08
- Revenue Growth
- HONE N/A
- CRMD N/A
- 52 Week Low
- HONE $8.89
- CRMD $3.61
- 52 Week High
- HONE $14.00
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- HONE 66.52
- CRMD 71.85
- Support Level
- HONE $10.93
- CRMD $8.72
- Resistance Level
- HONE $11.61
- CRMD $9.82
- Average True Range (ATR)
- HONE 0.32
- CRMD 0.67
- MACD
- HONE 0.13
- CRMD 0.40
- Stochastic Oscillator
- HONE 90.20
- CRMD 84.78
About HONE HarborOne Bancorp Inc.
HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in Boston, Massachusetts, and Providence, Rhode Island.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.